TuHURA Biosciences, Inc. (HURA) stock forecast and price target
Price $1.39 · data as of November 13, 2026
12-month price target
Average target$8.04
Upside / downside+478.4%
Analysts5
ConsensusStrong buy
Low $6.20Average $8.04High $10.00
Gold marker: average target · white marker: today’s price ($1.39)
Analyst ratings
Strong buy 2Buy 2Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.49 | +25.4% | $0 |
| Next fiscal year ends December 31, 2027 | $-0.62 | −27.6% | $0 |
| Next quarter ends December 31, 2026 | $-0.12 | +26.4% | $0 |
| Quarter after ends March 31, 2027 | $-0.15 | −15.4% | $0 |
Consensus of the analysts covering TuHURA Biosciences, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the TuHURA Biosciences stock price target?
The average 12-month target from 5 analysts is $8.04, 478.4% above the current price of $1.39 Targets range from $6.20 to $10.00.
Is TuHURA Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 2 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is TuHURA Biosciences expected to earn?
Analysts expect EPS of $-0.49 for the fiscal year ending December 31, 2026 and $-0.62 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.